Table 2.
Multivariable logistic regression analysis identifying variables associated with upstaging in patients with clinical stage I NSCLC.
| Patient and Treatment Variables | Odds ratio (OR) with 95% Confidence Interval (CI) | p-Value |
|---|---|---|
| Age | 0.99 (0.99–0.99) | <0.001 |
| Male gender | 1.11 (1.05–1.17) | <0.001 |
| Tumor Size (mm) | 1.11 (1.10–1.13) | <0.001 |
| Clinical T2 Status | 1.52 (1.42–1.62) | <0.001 |
| Latency > 8 weeks | 1.10 (1.03–1.16) | 0.002 |
| Positive Tumor Margin | 4.14 (3.70–4.63) | <0.001 |
| Squamous Histology | 0.82 (0.78–0.87) | <0.001 |
| Number of Lymph Nodes Examined (n) | ||
| n=0 (2,565) | 1.00 | n/a |
| n=1–3 (9,523) | 2.01 (1.62–2.50) | <0.001 |
| n=4–6 (11,848) | 2.99 (2.42–3.69) | <0.001 |
| n=7–9 (9,406) | 3.81 (3.09–4.71) | <0.001 |
| n=10–12 (6,562) | 4.19 (3.38–5.19) | <0.001 |
| n=13–15 (4,126) | 4.51 (3.62–5.62) | <0.001 |
| n=16–18 (2,514) | 5.90 (4.70–7.40) | <0.001 |
| n>18 (4,528) | 6.14 (4.94–7.62) | <0.001 |